These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 2165009

  • 1. Is the neuronal basis of Alzheimer's disease cholinergic or glutamatergic?
    Palmer AM, Gershon S.
    FASEB J; 1990 Jul; 4(10):2745-52. PubMed ID: 2165009
    [Abstract] [Full Text] [Related]

  • 2. [Pharmaceutical research strategies in Alzheimer's disease].
    Wülfert E.
    J Pharm Belg; 1991 Jul; 46(1):67-77. PubMed ID: 2051302
    [Abstract] [Full Text] [Related]

  • 3. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease.
    Gilmor ML, Erickson JD, Varoqui H, Hersh LB, Bennett DA, Cochran EJ, Mufson EJ, Levey AI.
    J Comp Neurol; 1999 Sep 06; 411(4):693-704. PubMed ID: 10421878
    [Abstract] [Full Text] [Related]

  • 4. [Pathophysiology of senile dementia].
    Karobath M.
    Schweiz Med Wochenschr; 1985 Dec 14; 115(50):1803-7. PubMed ID: 2868521
    [Abstract] [Full Text] [Related]

  • 5. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia.
    Chan-Palay V.
    J Comp Neurol; 1988 Jul 22; 273(4):543-57. PubMed ID: 2463283
    [Abstract] [Full Text] [Related]

  • 6. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function.
    Gibbs RB.
    Exp Neurol; 1998 Jun 22; 151(2):289-302. PubMed ID: 9628764
    [Abstract] [Full Text] [Related]

  • 7. Choline acetyltransferase activity and [3H]vesamicol binding in the temporal cortex of patients with Alzheimer's disease, Parkinson's disease, and rats with basal forebrain lesions.
    Ruberg M, Mayo W, Brice A, Duyckaerts C, Hauw JJ, Simon H, LeMoal M, Agid Y.
    Neuroscience; 1990 Jun 22; 35(2):327-33. PubMed ID: 2166243
    [Abstract] [Full Text] [Related]

  • 8. m2 muscarinic acetylcholine receptor-immunoreactive neurons are not reduced within the nucleus basalis in Alzheimer's disease: relationship with cholinergic and galaninergic perikarya.
    Mufson EJ, Jaffar S, Levey AI.
    J Comp Neurol; 1998 Mar 16; 392(3):313-29. PubMed ID: 9511920
    [Abstract] [Full Text] [Related]

  • 9. Sodium dependent D-[3H]aspartate binding in cerebral cortex in patients with Alzheimer's and Parkinson's diseases.
    Cross AJ, Slater P, Simpson M, Royston C, Deakin JF, Perry RH, Perry EK.
    Neurosci Lett; 1987 Aug 18; 79(1-2):213-7. PubMed ID: 2823192
    [Abstract] [Full Text] [Related]

  • 10. Choline acetyltransferase immunohistochemistry in brains of Alzheimer's disease patients and controls.
    Nagai T, McGeer PL, Peng JH, McGeer EG, Dolman CE.
    Neurosci Lett; 1983 Apr 11; 36(2):195-9. PubMed ID: 6866327
    [Abstract] [Full Text] [Related]

  • 11. Neurotransmitter and receptor deficits in senile dementia of the Alzheimer type.
    Quirion R, Martel JC, Robitaille Y, Etienne P, Wood P, Nair NP, Gauthier S.
    Can J Neurol Sci; 1986 Nov 11; 13(4 Suppl):503-10. PubMed ID: 2878714
    [Abstract] [Full Text] [Related]

  • 12. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
    Wu CK, Thal L, Pizzo D, Hansen L, Masliah E, Geula C.
    Exp Neurol; 2005 Oct 11; 195(2):484-96. PubMed ID: 16085017
    [Abstract] [Full Text] [Related]

  • 13. Molecular forms of acetylcholinesterases in Alzheimer's disease.
    Younkin SG, Goodridge B, Katz J, Lockett G, Nafziger D, Usiak MF, Younkin LH.
    Fed Proc; 1986 Dec 11; 45(13):2982-8. PubMed ID: 2430839
    [Abstract] [Full Text] [Related]

  • 14. Alterations in L-glutamate binding in Alzheimer's and Huntington's diseases.
    Greenamyre JT, Penney JB, Young AB, D'Amato CJ, Hicks SP, Shoulson I.
    Science; 1985 Mar 22; 227(4693):1496-9. PubMed ID: 2858129
    [Abstract] [Full Text] [Related]

  • 15. Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease.
    Lehéricy S, Hirsch EC, Cervera-Piérot P, Hersh LB, Bakchine S, Piette F, Duyckaerts C, Hauw JJ, Javoy-Agid F, Agid Y.
    J Comp Neurol; 1993 Apr 01; 330(1):15-31. PubMed ID: 8468401
    [Abstract] [Full Text] [Related]

  • 16. Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease.
    Perry RH, Candy JM, Perry EK, Irving D, Blessed G, Fairbairn AF, Tomlinson BE.
    Neurosci Lett; 1982 Dec 13; 33(3):311-5. PubMed ID: 7162693
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-132 and early growth response-1 in nucleus basalis of Meynert during the course of Alzheimer's disease.
    Zhu QB, Unmehopa U, Bossers K, Hu YT, Verwer R, Balesar R, Zhao J, Bao AM, Swaab D.
    Brain; 2016 Mar 13; 139(Pt 3):908-21. PubMed ID: 26792551
    [Abstract] [Full Text] [Related]

  • 18. Acetylcholine, aging, and Alzheimer's disease.
    Muir JL.
    Pharmacol Biochem Behav; 1997 Apr 13; 56(4):687-96. PubMed ID: 9130295
    [Abstract] [Full Text] [Related]

  • 19. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain.
    Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR.
    Science; 1982 Mar 05; 215(4537):1237-9. PubMed ID: 7058341
    [Abstract] [Full Text] [Related]

  • 20. Colchicine lesions in the rat hippocampus mimic the alterations of several markers in Alzheimer's disease.
    Nakagawa Y, Nakamura S, Kaśe Y, Noguchi T, Ishihara T.
    Brain Res; 1987 Apr 07; 408(1-2):57-64. PubMed ID: 2885069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.